Peter Kies - May 20, 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
/s/ Peter Kies
Stock symbol
INO
Transactions as of
May 20, 2025
Transactions value $
$0
Form type
4
Date filed
5/21/2025, 04:57 PM
Previous filing
May 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIES PETER CFO C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE ROAD, SAN DIEGO /s/ Peter Kies 2025-05-21 0001259780

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Award $0 +26.1K $0.00 26.1K May 20, 2025 Common Stock 26.1K Direct F1
transaction INO Common Stock Option Award $0 +32K $0.00 32K May 20, 2025 Common Stock 32K $2.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The vesting schedule for the 31,950 options is as follows: 15,975 shares will vest on May 20, 2027 and 15,975 shares will vest on May 20, 2028.